MedX Health Corp (MDX.V)
- Previous Close
0.0900 - Open
0.0950 - Bid 0.0900 x --
- Ask 0.1000 x --
- Day's Range
0.0950 - 0.1000 - 52 Week Range
0.0300 - 0.1100 - Volume
19,000 - Avg. Volume
172,676 - Market Cap (intraday)
26.196M - Beta (5Y Monthly) 1.41
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Apr 29, 2024 - May 3, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.
www.medxhealth.comRecent News: MDX.V
Performance Overview: MDX.V
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDX.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDX.V
Valuation Measures
Market Cap
26.20M
Enterprise Value
31.84M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
33.51
Price/Book (mrq)
--
Enterprise Value/Revenue
52.84
Enterprise Value/EBITDA
-9.83
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-277.82%
Return on Equity (ttm)
--
Revenue (ttm)
602.57k
Net Income Avi to Common (ttm)
-5.36M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
186.15k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.18M
Company Insights: MDX.V
MDX.V does not have Company Insights